Congenica
Cambridge, GB · 11 known investors
Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories. The platform enables rapid identification and prioritization of clinically relevant genetic variants from sequencing data, with applications in cancer mutation detection, germline variant analysis, and pathogen identification.
Investors · 11
Also in the syndicate · 4
Funding
SEC filings, press & company announcements$50M disclosed across 1 of 2 rounds · 2020
- $50MSeries CNov 2020 · 2 sources
Legal & General (lead), Tencent (lead), Cambridge Innovation Capital, Downing, IDO Investments, Parkwalk, Puhua Capital, Xeraya
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- CONGENICA LTD
- Company number
- 08273616
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 30 Oct 2012
- Registered office
- Bic Wellcome Genome Campus, Hinxton, Cambridge, CB10 1DR
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 30 Oct 2025 · next due 13 Nov 2026
Current officers · 3
- Pramex International Ltd — corporate secretary, appointed 16 Dec 2025
- Martin Dubuc — director, appointed 1 Sept 2025
- Alexander Kurze — director, appointed 28 Nov 2025
Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Congenica do?
- Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories. The platform enables rapid identification and prioritization of clinically relevant genetic variants from sequencing data, with applications in cancer mutation detection, germline variant analysis, and pathogen identification.
- Who are Congenica's investors?
- Congenica's investors include Cambridge Innovation Capital, QVentures, Amadeus Capital Partners, Future Planet Capital, IDO Investments, Legal & General, Puhua Capital.
- How much funding has Congenica raised?
- Congenica has disclosed $50M raised across 1 of its 2 known rounds.
- Where is Congenica headquartered?
- Congenica is headquartered in Cambridge, GB.